Alacrita, a transatlantic life sciences consulting firm, has strengthened its Cambridge, MA office with the appointment of William (Bill) Slichenmyer as an Associate Partner.
The company, which also has an office in London, UK, says the move consolidates its position as a provider of advice to life science companies looking to develop and launch novel therapeutic agents.
For more than 20 years Slichenmyer has held leadership and executive roles in large and small pharma companies including AVEO Oncology, Pfizer, Parke-Davis, Bristol-Myers Squibb, Merrimack Pharmaceuticals and Hybridon. His responsibilities in these roles have spanned clinical development, medical affairs and regulatory affairs, from preclinical development to post-marketing trials.
